Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome
Abstract Background Patients with metabolic syndrome (MetS) are at increased risk of asymptomatic hyperuricemia (i.e., elevated serum uric acid (SUA) level without gout) and cardiovascular disease. We conducted a cross-sectional study to examine associations between SUA levels and coronary flow rese...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | BMC Rheumatology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41927-018-0027-6 |
id |
doaj-bac6e76264854c619d2e8b77583bf5dd |
---|---|
record_format |
Article |
spelling |
doaj-bac6e76264854c619d2e8b77583bf5dd2020-11-25T01:51:14ZengBMCBMC Rheumatology2520-10262018-06-01211710.1186/s41927-018-0027-6Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndromeSeoyoung C. Kim0Marcelo F. Di Carli1Rajesh K. Garg2Kathleen Vanni3Penny Wang4Alyssa Wohlfahrt5Zhi Yu6Fengxin Lu7Anarosa Campos8Courtney F. Bibbo9Stacy Smith10Daniel H. Solomon11Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Nuclear Medicine, Department of Radiology, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Endocrinology, Diabetes & Hypertension, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Nuclear Medicine, Department of Radiology, Brigham and Women’s Hospital, Harvard Medical SchoolDepartment of Radiology, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolAbstract Background Patients with metabolic syndrome (MetS) are at increased risk of asymptomatic hyperuricemia (i.e., elevated serum uric acid (SUA) level without gout) and cardiovascular disease. We conducted a cross-sectional study to examine associations between SUA levels and coronary flow reserve and urate deposits in carotid arteries in patients with asymptomatic hyperuricemia and MetS. Methods Adults aged ≥40 years with MetS and SUA levels ≥6.5 mg/dl, but no gout, were eligible. Using a stress myocardial perfusion positron emission tomography (PET), we assessed myocardial blood flow (MBF) at rest and stress and calculated coronary flow reserve (CFR). CFR < 2.0 is considered abnormal and associated with increased cardiovascular risk. We also measured insulin resistance by homeostatic model assessment (HOMA-IR) method and urate deposits using dual-energy CT (DECT) of the neck for the carotid arteries. Results Forty-four patients with the median age of 63.5 years underwent a blood test, cardiac PET and neck DECT scans. Median (IQR) SUA was 7.8 (7.1–8.4) mg/dL. The median (IQR) CFR was abnormally low at 1.9 (1.7–2.4) and the median (IQR) stress MBF was 1.7 (1.3–2.2) ml/min/g. None had urate deposits in the carotid arteries detected by DECT. In multivariable linear regression analyses, SUA had no association with CFR (β = − 0.12, p = 0.78) or stress MBF (β = − 0.52, p = 0.28). Among non-diabetic patients (n = 25), SUA was not associated with HOMA-IR (β = 2.08, p = 0.10). Conclusions Among MetS patients with asymptomatic hyperuricemia, we found no relationship between SUA and CFR, stress MBF, and insulin resistance. No patients had any DECT detectable subclinical urate deposition in the carotid arteries.http://link.springer.com/article/10.1186/s41927-018-0027-6Uric acidMetabolic syndromePET/CTDECTCoronary blood flow |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Seoyoung C. Kim Marcelo F. Di Carli Rajesh K. Garg Kathleen Vanni Penny Wang Alyssa Wohlfahrt Zhi Yu Fengxin Lu Anarosa Campos Courtney F. Bibbo Stacy Smith Daniel H. Solomon |
spellingShingle |
Seoyoung C. Kim Marcelo F. Di Carli Rajesh K. Garg Kathleen Vanni Penny Wang Alyssa Wohlfahrt Zhi Yu Fengxin Lu Anarosa Campos Courtney F. Bibbo Stacy Smith Daniel H. Solomon Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome BMC Rheumatology Uric acid Metabolic syndrome PET/CT DECT Coronary blood flow |
author_facet |
Seoyoung C. Kim Marcelo F. Di Carli Rajesh K. Garg Kathleen Vanni Penny Wang Alyssa Wohlfahrt Zhi Yu Fengxin Lu Anarosa Campos Courtney F. Bibbo Stacy Smith Daniel H. Solomon |
author_sort |
Seoyoung C. Kim |
title |
Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome |
title_short |
Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome |
title_full |
Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome |
title_fullStr |
Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome |
title_full_unstemmed |
Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome |
title_sort |
asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome |
publisher |
BMC |
series |
BMC Rheumatology |
issn |
2520-1026 |
publishDate |
2018-06-01 |
description |
Abstract Background Patients with metabolic syndrome (MetS) are at increased risk of asymptomatic hyperuricemia (i.e., elevated serum uric acid (SUA) level without gout) and cardiovascular disease. We conducted a cross-sectional study to examine associations between SUA levels and coronary flow reserve and urate deposits in carotid arteries in patients with asymptomatic hyperuricemia and MetS. Methods Adults aged ≥40 years with MetS and SUA levels ≥6.5 mg/dl, but no gout, were eligible. Using a stress myocardial perfusion positron emission tomography (PET), we assessed myocardial blood flow (MBF) at rest and stress and calculated coronary flow reserve (CFR). CFR < 2.0 is considered abnormal and associated with increased cardiovascular risk. We also measured insulin resistance by homeostatic model assessment (HOMA-IR) method and urate deposits using dual-energy CT (DECT) of the neck for the carotid arteries. Results Forty-four patients with the median age of 63.5 years underwent a blood test, cardiac PET and neck DECT scans. Median (IQR) SUA was 7.8 (7.1–8.4) mg/dL. The median (IQR) CFR was abnormally low at 1.9 (1.7–2.4) and the median (IQR) stress MBF was 1.7 (1.3–2.2) ml/min/g. None had urate deposits in the carotid arteries detected by DECT. In multivariable linear regression analyses, SUA had no association with CFR (β = − 0.12, p = 0.78) or stress MBF (β = − 0.52, p = 0.28). Among non-diabetic patients (n = 25), SUA was not associated with HOMA-IR (β = 2.08, p = 0.10). Conclusions Among MetS patients with asymptomatic hyperuricemia, we found no relationship between SUA and CFR, stress MBF, and insulin resistance. No patients had any DECT detectable subclinical urate deposition in the carotid arteries. |
topic |
Uric acid Metabolic syndrome PET/CT DECT Coronary blood flow |
url |
http://link.springer.com/article/10.1186/s41927-018-0027-6 |
work_keys_str_mv |
AT seoyoungckim asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome AT marcelofdicarli asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome AT rajeshkgarg asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome AT kathleenvanni asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome AT pennywang asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome AT alyssawohlfahrt asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome AT zhiyu asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome AT fengxinlu asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome AT anarosacampos asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome AT courtneyfbibbo asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome AT stacysmith asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome AT danielhsolomon asymptomatichyperuricemiaandcoronaryflowreserveinpatientswithmetabolicsyndrome |
_version_ |
1724997729032077312 |